Related Experiment Video

Updated: Jun 30, 2026

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

[Expression of PDCD5 in multiple myeloma and its relation with BCL-2]

Tie-Bin Jiang1, Xin Li, Jun Zhou

  • 1Department of Hematology, Third Xiangya Hospital, Central South University, Changsha 410013, China.

Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences
|September 25, 2008
PubMed
Abstract

Insights

In multiple myeloma (MM), programmed cell death 5 (PDCD5) expression is reduced while BCL-2 expression is increased. PDCD5 and BCL-2 show a negative correlation in MM patients.

Area of Science:

  • Molecular Biology
  • Oncology

Context:

  • Multiple myeloma (MM) is a hematological malignancy characterized by uncontrolled proliferation of plasma cells.
  • Apoptosis-related genes play crucial roles in the pathogenesis and progression of MM.
  • Understanding the expression patterns of key apoptosis regulators like PDCD5 and BCL-2 is vital for MM research.

Purpose:

  • To investigate the expression levels of the apoptosis-related gene PDCD5 in multiple myeloma (MM).
  • To analyze the relationship between PDCD5 and BCL-2, another key regulator of apoptosis, in MM.

Summary:

  • This study quantified PDCD5 and BCL-2 protein and mRNA expression in MM patients and healthy controls using immunohistochemistry, flow cytometry, and RT-PCR.
  • Results indicated significantly down-regulated PDCD5 expression and up-regulated BCL-2 expression in MM patients compared to controls.
  • A significant negative correlation was observed between PDCD5 and BCL-2 expression at both protein and mRNA levels in MM.

Impact:

  • The findings suggest that altered expression of PDCD5 and BCL-2 may contribute to the pathophysiology of multiple myeloma.
  • This research provides insights into the molecular mechanisms underlying apoptosis dysregulation in MM.
  • The identified negative correlation between PDCD5 and BCL-2 highlights potential therapeutic targets for MM treatment.

More Related Videos

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...